Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

BACKGROUND: Individuals with primary and secondary immunodeficiency (PID/SID) were shown to be at risk of poor outcomes during the early stages of the SARS-CoV-2 pandemic. SARS-CoV-2 vaccines demonstrate reduced immunogenicity in these patients. OBJECTIVES: To understand whether the risk of severe C...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Adrian M., Tadros, Susan, Al-Hakim, Adam, Nell, Jeremy M., Lin, Me Me Nay, Chan, Michele, Goddard, Sarah, Dempster, John, Dziadzio, Magdalena, Patel, Smita Y., Elkalifa, Shuayb, Huissoon, Aarnoud, Duncan, Christopher J. A., Herwadkar, Archana, Khan, Sujoy, Bethune, Claire, Elcombe, Suzanne, Thaventhiran, James, Klenerman, Paul, Lowe, David M., Savic, Sinisa, Burns, Siobhan O., Richter, Alex G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539662/
https://www.ncbi.nlm.nih.gov/pubmed/36211396
http://dx.doi.org/10.3389/fimmu.2022.984376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539662/
https://www.ncbi.nlm.nih.gov/pubmed/36211396
http://dx.doi.org/10.3389/fimmu.2022.984376

Ejemplares similares